Skip to main content
OpenTrials
Completed

NCT Number: NCT01058694

The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya

The purpose of proposed research is to implement a randomized study that will allow us to understand and address a number of key barriers to patient adherence as well as study the effects of better adherence on health and socio-economic outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

AIDS Acquired Immunodeficiency Syndrome Antiretroviral Therapy Behavior Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Health Behavior Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Medication Adherence Patient Acceptance of Health Care Patient Compliance RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Treatment Adherence and Compliance Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chulaimbo Rural Health Center

Kisumu, Maseno District, Kenya

About this study

Several studies have shown that proper adherence to treatment regimens is essential for the effectiveness of ARV therapy (e.g Wools-Kaloustian et al. 2006). There is also evidence in that in some treatment programs in Africa, adherence rates are not always high (Gill et al. 2005). Even in settings where adherence levels are found to be high, numerous factors have been identified as being relevant, although the causal effects are unknown (Castro, 2006). As ARV treatment programs are scaled up in Africa, it is essential to understand the socio-economic determinants of adherence to ARV treatment, as well as the impact of interventions to support high levels of adherence. A secondary objective of this study is to understand the socio-economic impacts of higher adherence.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who had been on ARV therapy at the Chulaimbo Rural Health Center for a maximum of three months and providing consent to participate in the study.

Exclusion criteria

  • Patients who had been on ARV therapy for more than 3 months.

Treatment and study plan

Short Message Services to Support ARV therapy adherence

Behavioral

Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design.

Primary outcomes

  1. MEMS Adherence

    Time frame: 12 months follow up

Secondary outcomes

  1. Frequency/incidence of ARV treatment interruptions

    Time frame: 12 months follow up

Sponsors and collaborators

Lead sponsor

Georgetown University

Other

Collaborators

  • Columbia University
  • Harvard University
  • Indiana University
  • Moi Univeristy
  • University of California, San Diego
  • University of North Carolina
  • World Bank

Registry information

Official study title

Adherence to ARV Treatment and Its Effects on Medium Run Socio-Economic Outcomes: Evidence From Western Kenya

Acronym: CAPS

Important dates

Study start
2007
Primary completion
2008
Study completion
2009
First posted
Jan 29, 2010
Registry last updated
Jan 29, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.